Hyun C. Chung, MD, PhD, professor at Yonsei Cancer Center, Yonsei University College of Medicine in Seoul, Republic of Korea, discusses the rationale of the KEYNOTE-811 study in HER2-positive gastric cancer. Website:
Twitter:
Facebook:
LinkedIn:
Dr. Chung on the Rationale of the KEYNOTE-811 Trial in HER2+ Gastric Cancer
Hyun C. Chung, MD, PhD, professor at Yonsei Cancer Center, Yonsei University College of Medicine in Seoul, Republic of Korea, discusses the rationale of the KEYNOTE-811 study in HER2-positive gastric cancer. Website:
Twitter:
Facebook:
LinkedIn:
0 Comments